NASD · Healthcare · Medical Care Facilities · USA
WW International Inc is a micro cap company (market value under $300 million) in the Medical Care Facilities industry.
WW International operates Weight Watchers, a weight management program combining community support with personalized nutrition, behavioral science, and digital tools. The company offers three membership tiers: Core with its Points Program, Core+ adding coaching and workshops, and Med+ providing healthcare access and FDA-approved medications for eligible U.S. members. Revenue derives from subscription-based offerings.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the WW International Inc stock.
No reliable verdict: intrinsic value $97.18 per share, market price $8.96 (as of 2026-11-17).
Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $97.18: 11 times the price of $8.96. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
10 more funds hold it; the full list is part of the paid plan.
All 48 Medical Care Facilities stocks
We do not publish a verdict on WW. Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $97.18: 11 times the price of $8.96. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
We do not publish one (as of the 2026-11-17 close). Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $97.18: 11 times the price of $8.96. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.